💡 50% of hires happen without a job posting·⚡ Apply spontaneously to dozens of companies📈 Track opens & CV clicks
Vésale Pharma
Public profile- Noville-sur-Méhaigne, Belgium
- 11-50 collaborators
- Pharmaceutical/Biotech
- and 1 others
- Noville-sur-Méhaigne, Belgium
- 11-50 collaborators
- Pharmaceutical/Biotech
- and 1 others
Overview Vésale Pharma
https://vesalepharma.com/en/About us
What we do: Vésale Pharma is a Belgian pharmaceutical company specializing in the research, development, and commercialization of innovative health solutions, with a strong focus on probiotic food supplements. Our core business revolves around creating advanced probiotic therapies, including unique micro-encapsulation technologies such as Intelicaps®, which significantly enhance the stability and efficacy of probiotic products. We serve the healthcare industry, offering a comprehensive portfolio that covers pediatric, women’s health, and adult therapeutic needs. Our products are marketed in approximately twenty countries, and we collaborate with leading international research institutions, including the Institut Pasteur of Lille and Texas A&M University, to drive innovation in digestive, immune, and feminine health[2][3].
Where we are located: Our headquarters is located at Rue Louis Allaert, 5310 Éghezée, in the Walloon Region of Belgium. This site houses both our administrative offices and production facilities, serving as the central hub for our operations and innovation activities[1][2].
Short history: Founded in 1996, Vésale Pharma has established itself as a pioneer in probiotic R&D. Over the years, we have secured six worldwide patents, with Intelicaps® being a standout innovation in probiotic micro-encapsulation. The company has consistently invested a significant portion of its turnover (23%) in research and development, focusing on probiotic therapy, applied metabolomics, and phagotherapy. In May 2025, Vésale Pharma was acquired by Ceres Pharma, marking a new chapter in our mission to deliver cutting-edge healthcare solutions[1][2].
Organization & culture: Vésale Pharma employs around fifty dedicated professionals across its production and headquarters sites. We foster a culture of innovation, collaboration, and integrity, where diverse ideas and skills are valued. Our team is passionate about making a positive impact on global health, and we believe that every member plays a crucial role in achieving our shared goals. The company’s human-centered approach ensures a supportive environment where employees can thrive and contribute to our collective success[2].
Recent developments: In 2024, Vésale Pharma continues to expand its global presence, participating in major industry events and launching new products such as KeraVit, a hair and nail wellness solution. Our commitment to innovation is further demonstrated by ongoing collaborations with academic and industry partners, as well as our recognition for excellence in probiotic technology. The acquisition by Ceres Pharma in 2025 positions us for further growth and reinforces our leadership in the healthcare sector[1][6].
Company roles mapping
This mapping combines roles declared by the company and roles identified by artificial intelligence from public data or past job offers. Some job titles are also standardised according to the European ESCO nomenclature (European Skills, Competences, Qualifications and Occupations) to ensure consistency with European skills frameworks. Learn more about AI transparency and ESCO →
No roles detected yet
The available public data does not yet allow us to identify the roles present with sufficient confidence. This mapping will automatically enrich itself as new information becomes available.
Employee distribution by work field
Estimate based on public data and company information. Learn more about AI transparency →
